References
- Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer 2011; 11:393-410; PMID:21606941; http://dx.doi.org/10.1038/nrc3064
- Sulli G, Di Micco R, d'Adda di Fagagna F. Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer. Nat Rev Cancer 2012; 12:709-20; PMID:22952011; http://dx.doi.org/10.1038/nrc3344
- Olcina MM, Grand RJ, Hammond EM. ATM activation in hypoxia - causes and consequences. Mol Cell Oncol 2014; 1:e29903; PMID:27308313; http://dx.doi.org/10.4161/mco.29903
- Rezaeian AH, Li CF, Wu CY, Zhang X, Delacerda J, You MJ, Han F, Cai Z, Jeong YS, Jin G, et al. A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1alpha activation, tumorigenesis and metastasis. Nat Cell Biol 2017; 19:38-51; PMID:27918549; http://dx.doi.org/10.1038/ncb3445
- Yang WL, Wang J, Chan CH, Lee SW, Campos AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG, et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 2009; 325:1134-8; PMID:19713527; http://dx.doi.org/10.1126/science.1175065
- Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science 2010; 330:517-21; PMID:20966255; http://dx.doi.org/10.1126/science.1192912